Digital Health Global

APRIL 25, 2024

About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.

Health Data 88

Health Data BioTech Drug Development healthcare technology 88

Digital Health Global

MARCH 2, 2023

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

Drug Development 88

Drug Development Life Science BioTech Leadership 88

Healthcare IT Today

JANUARY 8, 2024

Now, they have new tools such as artificial intelligence (AI) and machine learning (ML) that they can leverage to automatically scour medical literature for information to assist signal evaluation and medical review, or real-world-evidence insights that can lead to drug-safety improvements. Dave Latshaw, CEO at BioPhy 1.

Health IT 89

Health IT Drug Development Pharmaceuticals BioTech 89

Digital Health Global

JUNE 13, 2023

We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights. The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Healthcare IT Today

MARCH 23, 2023

With the additional funding, Protai will expand its activities to include an oncology drug discovery pipeline, initially focusing on targets with a clearly-defined novel patient population biomarker, derived from its AI proteomics platform. In addition, Protai is supported by leading oncology experts, including Prof.

Drug Development 96

Drug Development BioTech Health IT Healthcare IT 96

Digital Health Global

MARCH 26, 2024

Indivi is dedicated to unlocking the immense potential of digital biomarkers in drug development and healthcare by creating a unique symbiotic intersection between expert knowledge in Data Science, Clinical Science and Advanced Analytics (including machine learning and artificial intelligence).

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Society for Participatory Medicine

AUGUST 17, 2022

For a person like me, who is impacted by a rare, neurological, and incurable disease, it’s my mission to ensure that patients’ perspectives are represented early and throughout drug development. We plan to gather these stakeholders at the upcoming Huntington Study Group conference this November 3-5 in Tampa, FL, to develop next steps.

Drug Development 81

Drug Development BioTech 81

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Society for Participatory Medicine

JANUARY 11, 2022

As a leader in patient advocacy, I am often asked to speak on the topic of patient centricity and patient advocacy from the biotech/pharma perspective. Meaningfully incorporating this insight in all areas of our work must be the cornerstone of participatory medicine for drug development and access. Did you enjoy this post?

Drug Development 81

Drug Development BioTech Patient Experience Pharmaceuticals 81

Digital Health Global

APRIL 10, 2023

–(BUSINESS WIRE)– Aviceda Therapeutics , a clinical-stage biotech company focused on developing next-generation immuno-modulators to treat diseases such as cancer, today announced a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (Queen’s). CAMBRIDGE, Mass.–(BUSINESS

Life Science 88

Life Science BioTech Drug Development Health science 88

Digital Health Global

NOVEMBER 20, 2023

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally.

Life Science 88

Life Science Drug Development Digital Health Patient Experience 88

Digital Health Global

SEPTEMBER 27, 2023

About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Since our inception in 2022, ClavystBio has committed over US$220m to biotech, diagnostics, and digital health companies, as well as early-stage VC funds.

Life Science 88

Life Science Drug Development HC BioTech 88

Lloyd Price

DECEMBER 2, 2024

SolasCure: This UK-based biotech company raised £15 million to develop a wound cleaning product based on an enzyme cloned from medical maggots. Pixacare: This French startup raised €3 million to automate wound care monitoring using AI-powered technology.

Digital Health 57

Digital Health healthcare technology Telemedicine Leadership 57

Digital Health Global

MARCH 16, 2023

Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Lloyd Price

DECEMBER 8, 2018

Existing investors include biotech giant Celgene Corp. , But key facets of its business didn’t develop as planned, say people familiar with the company. It had hoped to sell analytics to pharmaceutical companies as they increasingly incorporated genetic sequencing into drug development, these people say.

Pharmaceuticals 57

Pharmaceuticals Life Science BioTech Drug Development 57

Healthcare IT Today

APRIL 25, 2024

In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drug development processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery.

Pharmaceuticals 135

Pharmaceuticals Drug Development BioTech Life Science 135

Healthcare IT Today

SEPTEMBER 28, 2022

Already, this real-world, distributed time of diagnosis approach, has been used to cut down more than four years of estimated drug development timeline in the instance of PRAX-222, a new therapy for SCN2A, a rare genetic disorder of pediatric epilepsy.

Drug Development 111

Drug Development BioTech Pain management Healthcare IT 111

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Healthcare IT Today

JANUARY 9, 2023

The new year will bear witness to great innovation in biotech in the precision oncology space. In 2023, we will see more pharma companies integrating precision medicine programs with drug development programs, as well as increasing regulation on precision medicine solutions and/or tools that are combining machine learning and AI.

Health IT 82

Health IT Pharmaceuticals Drug Development Life Science 82

Healthcare Innovation Consortium

OCTOBER 24, 2023

We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded.

BioTech 60

BioTech Drug Development Healthcare Innovation Medical Technology 60

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.” For more information, please visit www.rac a p.com. About Sanofi Ventures Sanofi Ventures is the corporate venture capital arm of Sanofi.

Life Science 88

Life Science BioTech Drug Development Digital Health 88